Embolic protection device does not reduce stroke rate in TAVR procedure

Embolic protection device does not reduce stroke rate in TAVR procedure

A device designed to remove embolic material—fragments of tissue that can be released into the bloodstream during transcatheter aortic valve replacement (TAVR)—did not result in a reduction in the rate of stroke, according to a randomized trial presented at the American College of Cardiology's Annual Scientific Session.

Cerebral Embolic Protection for TAVI Doesn't Cut Strokes, Trial Affirms

(MedPage Today) -- CHICAGO -- Routine use of devices to prevent cerebral emboli during transcatheter aortic valve implantation (TAVI) did not prevent strokes, a large randomized trial showed. Incidence of stroke within 72 hours after TAVI or...

An intervention of historic importance at San Camillo Forlanini. For the first time in literature, the hospital performed a Tavi (Transcatheter Aortic Valve Implantation) intervention in Tavi, with the implantation of a new aortic bioprosthesis from the femoral artery inside a previous...

Documentary on cerebral palsy by KU's EMRC wins National level award

Srinagar, Mar 30: The University of Kashmir’s (KU’s) Educational Multimedia Research Centre (EMRC) has brought home a prestigious accolade as its documentary, ‘Parenting Special Needs Children: Cerebral Palsy,’ was awarded best programme in the Teacher Education category at the All-India Children’s Educational e-content Competition (AICEeCC) 2024-25. The three-day national-level competition, organized by the Central Institute of Educational Tech…

ACC.25: Cerebral embolic protection found not to reduce stroke in BHF PROTECT TAVI trial - Cardiovascular News

Rajesh Kharbanda Use of cerebral embolic protection with the Sentinel (Boston Scientific) device during transcatheter aortic valve implantation (TAVI) did not result in a reduction in the rate of stroke, data from the randomised BHF PROTECT-TAVI trial have shown. Results from the trial, which is the largest randomised trial to assess the use of a cerebral embolic protection device during TAVI, were presented during a late-breaking trial session …